Cipla posted lower than expected numbers for 1QFY2017. Sales came in at
Rs3,500cr V/s Rs3,743cr expected and V/s Rs3,761cr in 1QFY2016, a dip of 6.9%
yoy. Domestic sales (Rs1,449cr) rose 5% yoy, while exports (Rs2,051cr) dipped by
14.0% yoy. On the operating front, the EBITDA margin came in at 14.8% V/s
18.6% expected, V/s 26.0% in 1QFY2016, and V/s Adj. OPM of 15.8% in
4QFY2016. Thus, the Adj. net profit came in at Rs365cr V/s Rs435cr expected and
V/s Rs649cr in 1QFY2016, a yoy de-growth of 43.7%. We maintain our Neutral
rating on the stock.
Results much lower than our expectations: The company posted lower than
expected numbers for 1QFY2017. Sales came in at Rs3,500cr V/s Rs3,743cr
expected and V/s Rs3,761cr in 1QFY2016, a dip of 6.9% yoy. Domestic sales
(Rs1,449cr) rose 5% yoy, while exports (Rs2,051cr) dipped by 14.0% yoy. On the
operating front, the EBITDA margin came in at 14.8% V/s 18.6% expected, V/s
26.0% in 1QFY2016, and V/s Adj. OPM of 15.8% in 4QFY2016. Thus, the Adj.
net profit came in at Rs365cr V/s Rs435cr expected and V/s Rs649cr in 1QFY2016,
a yoy de-growth of 43.7%.
Outlook and valuation: We expect the company to post a 16.3% CAGR in
net sales to Rs18,089cr and EPS to record a 20.4% CAGR to Rs27.2 over
FY2016–18E. We reiterate our Neutral stance on the stock owing to the
company’s poor return ratios.
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...